Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril

Niranjan Maitra, Cynthia Adamson, Kevin Greer, Scott Klewer, James Hoying, Joseph J. Bahl, Steven Goldman, Eugene Morkin

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

We have used an oligonucleotide microarray to identify genes that are affected by congestive heart failure and those influenced by treatment with DITPA and DITPA in combination with captopril using a rat postinfarction model. The most striking result when comparing heart failure to sham operation was that all of the mitochondrial and metabolic enzymes affected were down regulated. When comparing heart failure with DITPA treatment, most of the down regulated metabolic genes were returned toward normal. When comparing heart failure with heart failure animals treated with DITPA and captopril, metabolic enzymes were no longer significantly downregulated. DITPA treatment and the combination of DITPA and captopril show that the metabolic enzymes were no longer down regulated. This represents a substantial improvement in the energy- generating capacity of the heart. These results indicate that the actions of DITPA and the combination of DITPA and captopril in heart failure can be partially explained by differences in gene activation.

Original languageEnglish (US)
Pages (from-to)526-534
Number of pages9
JournalJournal of Cardiovascular Pharmacology
Volume50
Issue number5
DOIs
StatePublished - Nov 1 2007

    Fingerprint

Keywords

  • Captopril
  • DITPA
  • Genes
  • Metabolic enzymes

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this